Cargando…

Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma

Portal vein embolization (PVE) for hepatocellular carcinoma (HCC) was first introduced in 1986 and has been continuously developed throughout the years. Basically, PVE has been applied to expand the indication of liver resection for HCC patients of insufficient future liver remnant. Importantly, PVE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beppu, Toru, Yamamura, Kensuke, Okabe, Hirohisa, Imai, Katsunori, Hayashi, Hiromitsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164464/ https://www.ncbi.nlm.nih.gov/pubmed/34095718 http://dx.doi.org/10.1002/ags3.12414

Ejemplares similares

Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
por: Koga, Yuki, et al.
Publicado: (2018)

A novel comprehensive ALPPS preoperative risk assessment (CAPRA) score is beneficial in creating a treatment strategy for advanced liver malignancy
por: Yamamura, Kensuke, et al.
Publicado: (2023)

Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy
por: Hayashi, Hiromitsu, et al.
Publicado: (2020)

The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
por: Beppu, Toru, et al.
Publicado: (2017)

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2018)

Ectopic hepatocellular carcinoma mimicking a retroperitoneal tumor: A case report
por: Adachi, Yuki, et al.
Publicado: (2020)

Role of Leukocyte Cell-Derived Chemotaxin 2 as a Biomarker in Hepatocellular Carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2014)

Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
por: Shao, Zhiying, et al.
Publicado: (2021)

Selective embolization of the splenic vein for shunt-preserving disconnection of the portal and systemic circulation: report of two cases
por: Ikeda, Osamu, et al.
Publicado: (2012)

Successful surgical rescue of delayed onset diaphragmatic hernia following radiofrequency ablation using a thoracoscopic approach for hepatocellular carcinoma: a case report
por: Morito, Atsushi, et al.
Publicado: (2021)

Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma
por: Yusa, Toshihiko, et al.
Publicado: (2022)

Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer
por: Sakamoto, Keita, et al.
Publicado: (2015)

Postoperative adjuvant chemo (embolization) therapy for hepatocellular carcinoma with portal vein tumor thrombosis
por: Zhang, Ya-Fei, et al.
Publicado: (2018)

Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis
por: Okabe, Hirohisa, et al.
Publicado: (2016)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021)

Lysyl oxidase induces epithelial‐mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma
por: Umezaki, Naoki, et al.
Publicado: (2019)

Complete necrosis of hepatocellular carcinoma after preoperative portal vein embolization: a case report
por: EL Bacha, H, et al.
Publicado: (2017)

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
por: Woo, Hyun Young, et al.
Publicado: (2015)

Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
por: Khan, Abdul Rehman, et al.
Publicado: (2021)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
por: He, Chengjian, et al.
Publicado: (2022)

Resectability of bilobar liver tumours after simultaneous portal and hepatic vein embolization versus portal vein embolization alone: meta-analysis
por: Korenblik, Remon, et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Sang Jin, et al.
Publicado: (2021)

Quality Improvement for Portal Vein Embolization
por: Denys, Alban, et al.
Publicado: (2010)

Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
por: Sun, Ju-Xian, et al.
Publicado: (2016)

Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges
por: Jiang, Jin-Fang, et al.
Publicado: (2017)

Portal vein embolization: rationale, techniques, outcomes and novel strategies
por: Chansangrat, Jirapa, et al.
Publicado: (2021)

Reactive lymphoid hyperplasia of the liver requires differential diagnosis of hepatocellular carcinoma
por: Higashi, Takaaki, et al.
Publicado: (2015)

Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus
por: Katagiri, Satoshi, et al.
Publicado: (2013)

Role of Portal Vein Embolization in Hepatocellular Carcinoma Management and Its Effect on Recurrence: A Case-control Study
por: Siriwardana, Rohan C., et al.
Publicado: (2012)

The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus
por: Bai, Tao, et al.
Publicado: (2016)

Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy
por: Zhang, Cheng-Wu, et al.
Publicado: (2020)

Case Report: Massive Hepatocellular Carcinoma Complete Surgical Resection After Portal Vein Embolization and Multimodality Therapy
por: Lin, Qianyi, et al.
Publicado: (2022)

Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
por: Kamiyama, Toshiya, et al.
Publicado: (2017)

Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma
por: Li, Zhenli, et al.
Publicado: (2023)

Portal vein embolization in children: As good as ALPPS
por: Wildhaber, Barbara Elisabeth, et al.
Publicado: (2021)

Spontaneous Massive Necrosis of Hepatocellular Carcinoma with Narrowing and Occlusion of the Arteries and Portal Veins
por: Tomino, Takahiro, et al.
Publicado: (2014)

The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
por: Bae, Bong Kyung, et al.
Publicado: (2016)

Combined simultaneous embolization of the portal vein and hepatic vein (double vein embolization) – a technical note about embolization sequence
por: Najafi, Arash, et al.
Publicado: (2021)

New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Yin, Jun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h4b0nn94k2u1fnpp4pkfsv02f3